While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. This evidence concerns the gene AQP5 and chronic myelogenous leukemia, BCR-ABL1 positive.